Fasting Insulin measures how much insulin is circulating in your blood after an overnight fast, usually reported in µU/mL (some labs print mIU/L, which is numerically the same). Insulin is the hormone released by beta cells in the pancreas, and its job at rest is to keep glucose moving out of the bloodstream into muscle, liver and fat cells while telling the liver to slow its own glucose production. A fasting sample captures the baseline amount of hormone your body needs simply to hold the line overnight, before any meal arrives.
What the marker is in full, how the sample is collected, the ranges labs use and what a single result may reflect all sit on the fasting insulin biomarker page linked above. This guide stays with the question in the title, how insulin differs from glucose and why the pair says more than either number alone.
Fasting glucose is a fuel level, fasting insulin is the signal managing that fuel. Glucose is a sugar circulating in the blood, reported in mg/dL or mmol/L. Insulin is a peptide hormone made in the pancreas, reported in µU/mL. One number tells you where the fuel sits. The other tells you what it is costing your body to keep it sitting there.
A thermostat analogy holds up reasonably well. Glucose is the temperature on the wall. Insulin is how hard the boiler is running to produce that temperature. Walk into two houses and both read 21 degrees. In one, the boiler ticks over quietly. In the other, it is running flat out against draughty windows. The reading on the wall is identical. The energy bill is not, and neither is the long term condition of the boiler.
That is the practical gap between the two tests. Fasting glucose reports the outcome. Fasting insulin reports the effort behind the outcome. When cells respond well to insulin, a small amount of hormone keeps overnight glucose in a narrow band. When cells respond less to the same signal, the pancreas usually compensates by releasing more, and for a long stretch of time that compensation works well enough that the glucose number stays unremarkable. Research suggests that insulin resistance is best defined as a reduced biological response to insulin, with raised circulating insulin acting as the body's compensation 1.
So the two markers are not interchangeable, and they are not two versions of the same measurement. They answer different questions. A glucose result answers how much sugar is in the blood right now. An insulin result answers how much hormonal work is going into that figure. Ordering one without the other leaves the other question unasked.
Because glucose is the last domino to fall. The body defends blood sugar aggressively, and it has a dial it can turn before the glucose number moves at all, which is insulin output. If muscle, liver and fat cells become less responsive, the pancreas raises the hormone level until the same job gets done. The result on paper is a perfectly ordinary fasting glucose produced by a far from ordinary amount of effort.
Three things are happening overnight in a fasting state. Muscle is taking up a modest amount of glucose. The liver is producing glucose to keep the brain supplied, and insulin is the brake on that production. Fat tissue is releasing fatty acids, and insulin restrains that too. If the brake needs more pressure to work, the pancreas supplies more pressure. The fasting glucose stays flat while the fasting insulin climbs, sometimes for years.
This is the single most useful thing to understand about the pair. A normal fasting glucose does not, by itself, tell you that glucose handling is effortless. It tells you the system is still compensating. Research suggests that insulin resistance is associated with obesity and with the wider cluster of findings known as the metabolic syndrome, which is why clinicians look beyond the glucose figure alone 1.
The reverse situation is informative too. If compensation becomes harder to sustain, the fasting glucose starts to drift upward, and at that point the glucose test finally reports a change that may have been building for a long time. Studies indicate that fasting indices built from insulin and glucose carry information about the later development of diabetes and prediabetes subtypes, although their predictive performance varies between populations 2.
None of this makes a normal glucose meaningless. It makes it incomplete. The observation is a normal sugar level. The possible meaning is either genuine metabolic ease or well compensated effort. The way to tell the two apart is to measure the hormone as well, and to review both with a clinician.
They are reported as two separate lines on the same report, in different units, each against its own reference range. Fasting glucose appears on most standard metabolic panels. Fasting insulin is usually an add on test that has to be requested, which is one reason many people have years of glucose readings and no insulin readings at all.
| Marker | What the sample measures | Typical lab reference range | FitScript optimal range |
|---|---|---|---|
| Fasting glucose | Glucose circulating in blood after an 8 to 12 hour fast | 70 to 99 mg/dL (about 3.9 to 5.5 mmol/L) | Not published in this guide |
| Fasting insulin | Insulin circulating in blood after an 8 to 12 hour fast | 2 to 18 µU/mL (printed as mIU/L by some labs) | 2 to 5 µU/mL |
These are typical lab reference ranges, and they vary by laboratory, assay, age and sex, so the range printed beside your own result is the one that applies to your sample. FitScript's optimal range is an optimization target rather than a diagnostic cut-off, and it is narrower than the standard reference range by design.
Most labs flag a fasting glucose between 100 and 125 mg/dL as above the reference range, and a value of 126 mg/dL or higher is the level a clinician would confirm with a repeat test before drawing any conclusion. Full detail on how the sugar side is measured and interpreted sits on the fasting glucose page.
One structural point matters here. The reference range for insulin is wide, and a wide range is a statistical description of the people who were tested, not a statement that every value inside it carries the same meaning. A reading of 16 µU/mL and a reading of 3 µU/mL both print as in range on many reports. They describe quite different amounts of hormonal work.
HOMA-IR is a simple index that combines fasting glucose and fasting insulin into one estimate of insulin resistance, which is exactly why the two tests belong together. The common formula multiplies fasting insulin in µU/mL by fasting glucose in mg/dL and divides by 405, or by fasting glucose in mmol/L divided by 22.5. You can run your own figures through the HOMA-IR calculator.
The logic of the index is the thermostat idea written as arithmetic. Hold glucose constant and raise insulin, the index rises. Hold insulin constant and raise glucose, the index rises. Either route describes a system that needs more hormone, more sugar, or both, to stay where it is.
It is an estimate, not a measurement. Studies indicate that the hyperinsulinaemic euglycaemic clamp is regarded as the reference method for quantifying insulin sensitivity, while fasting based surrogate indices are what most clinical and research settings actually use because the clamp is demanding to perform 3. Surrogates trade precision for practicality.
The caveats are worth knowing before you read too much into a decimal place. Research suggests that HOMA results have to be interpreted with care, because insulin assays are not standardised between laboratories and the original linear approximation is not interchangeable with the updated computer model 4. In practice that means a HOMA-IR from one lab is not perfectly comparable with one from another lab, and the trend in your own results from the same lab is usually more informative than a single figure compared against someone else's.
It also means HOMA-IR is a descriptive index rather than a verdict. It cannot distinguish between a person with a slightly raised value from poor sleep the week of the draw and a person with a persistently raised value. That distinction comes from repeat testing and from a clinician reading the result alongside everything else in the picture.
It may reflect compensation, the pancreas producing more hormone than average to keep a normal sugar level. That is the observation and the most common inference, and it is worth discussing with a clinician rather than acting on alone.
The step before interpretation is checking the conditions of the draw. Insulin is exquisitely responsive to food, so a short fast, a late meal, a sweetened drink or even a milky coffee before the blood draw can lift the number.
If the pattern is genuine and repeats, the practical meaning is that glucose handling currently takes more hormonal effort than average. Research suggests that insulin resistance brings consequences beyond blood sugar, because the same hormonal signal acts on fat tissue, the liver and the vasculature 1. This is the point of measuring insulin at all, since the glucose number on its own would have reported nothing.
The next step is a conversation, not a conclusion. A clinician will usually want the rest of the context, which means body composition, waist measurement, lipids, liver markers, sleep, activity, alcohol, family history and any medicines you take. Some prescription medicines influence glucose and insulin, and a licensed provider is the person to assess whether that applies to you. If any treatment is appropriate, a licensed provider decides that after reviewing you, not a lab value in isolation.
A low fasting insulin usually reflects a body that needs little hormone to hold glucose steady, which, alongside a normal glucose, is generally a favourable pattern. Lean, physically active people often sit at the lower end of the range, and FitScript's optimal range of 2 to 5 µU/mL sits in that lower region of the standard reference interval.
Context changes the reading entirely, though. A low insulin paired with a normal glucose describes efficiency. A low or low normal insulin paired with a rising or clearly raised glucose describes something different, because it suggests the hormone is not keeping pace with the sugar level. That combination is worth discussing with a clinician promptly rather than filing away.
A very long fast, a recent period of heavy energy restriction, or a sample taken after prolonged exercise can also pull the number down on the day. This is another reason a single value rarely settles anything on its own, and why the pairing with glucose carries most of the signal.
Yes, and that combination is read differently from the common high insulin pattern. When glucose is above range while fasting insulin sits low, the straightforward inference is that insulin output is not matching demand, rather than that cells are resisting a plentiful signal.
There are several reasons a clinician would consider, and sorting between them is a clinical job rather than a calculation. Beta cell output can decline over time in people with longstanding insulin resistance, so some people move through a high insulin phase and later show lower insulin with higher glucose. Other patterns involve reduced insulin production from the outset. Acute illness, infection or significant physiological stress can also raise glucose temporarily.
This is the clearest example of why one test cannot stand in for the other. A raised glucose alone does not say whether the problem is too little hormone or too little response to the hormone, and those two situations are managed very differently. Pairing the two tests, and sometimes adding further markers, is what separates them. A raised fasting glucose with symptoms such as marked thirst, frequent urination, blurred vision or unexplained weight loss is worth contacting a clinician about promptly.
Quite a lot, which is why both are interpreted as trends rather than snapshots. The length of the fast is the first variable, since insulin responds to the last meal far more sharply than glucose does and an 8 to 12 hour fast is the usual standard for both.
Short term influences worth knowing about include poor or short sleep in the nights before the draw, acute illness or infection, significant psychological stress, alcohol the night before, a very carbohydrate heavy meal the evening before, and hard exercise in the preceding day, which can push numbers in either direction depending on timing and intensity. Time of day matters because both markers follow a daily rhythm, so a mid morning draw is not strictly comparable with an early one.
Technical factors matter as much as biological ones. Insulin assays are not standardised across laboratories, so the same serum can produce different figures in different hands, and this is one of the reasons HOMA values are compared cautiously between settings 4. Sample handling counts too, since delays in separating serum and haemolysed samples can affect insulin measurement.
Then there is biology you did not choose. Research suggests that the heritability of fasting glucose, fasting insulin and insulin resistance indices is not constant across the population, and appears larger at the upper end of their distributions 5. In plain terms, two people with similar habits can genuinely sit at different baselines, which is an argument for tracking your own trajectory rather than comparing your figure with a friend's.
Both come from a single venous blood draw taken after an overnight fast, so there is no need for two appointments. The standard preparation is 8 to 12 hours without food or caloric drinks, with plain water allowed and encouraged, and most people book a morning slot to make that practical.
A few preparation details make results more comparable over time. Keep the fasting window similar from test to test. Take the sample at a similar time of day. Avoid alcohol the evening before and avoid unusually hard training the day before, unless your clinician specifically wants to see the effect of your normal routine. Note any illness in the preceding week, because an infection can shift both numbers.
Glucose is measured on a plasma or serum sample and is a well standardised assay. Insulin is measured by immunoassay on serum, and the sample benefits from prompt processing.
One more practical point. If the pair is being used to calculate HOMA-IR, both values must come from the same fasting sample. Combining a glucose from one month with an insulin from another produces an index that describes nothing in particular.
The two fasting markers are more useful inside a panel than on their own, because glucose handling touches lipids, liver and body composition. The usual companions are HbA1c, which reflects average glucose exposure over a period of months, triglycerides and HDL cholesterol, liver enzymes such as ALT, and in some cases C-peptide, which gives a different window on how much insulin the pancreas is producing.
Triglycerides deserve a specific mention next to glucose. Studies suggest that the triglyceride to glucose index performs comparably to HOMA-IR as a surrogate marker of insulin resistance, which is useful where fasting insulin is not available 6. Studies indicate that each of these surrogates has limitations compared with direct measurement, so they are read as indicators rather than final answers 3.
Beyond the blood, waist measurement and body composition add context that no assay provides, and a clinician will usually weigh them alongside the numbers. Where a fasting pair looks ambiguous, an oral glucose tolerance test with insulin measured at intervals gives a dynamic picture that a single resting sample cannot.
This is the case for panel based testing rather than single markers. FitScript's membership covers 150+ biomarkers tested per year, with results interpreted by Atlas, FitScript's AI health advisor, and any treatment decision made by a licensed provider after reviewing the member. The value of a panel is that it shows which systems are moving together, which is precisely the information a lone glucose reading cannot give you.
There is no universal interval, and the right frequency depends on your starting point, your goals and what your clinician is watching. What matters more than the calendar is consistency of conditions, because a trend built from comparable draws is far more readable than scattered results collected under different circumstances.
When you do repeat, hold the variables steady. Same laboratory where possible, similar fasting window, similar time of day, and a note of anything unusual in the preceding week. If you are making deliberate changes to sleep, training, body composition or diet, allow enough time for those changes to show before expecting the markers to move.
Read the direction, not the decimal. A fasting insulin drifting from the upper part of the reference range toward the lower part across several draws tells a clearer story than any single figure, and the same applies to the HOMA-IR index built from the pair. Studies indicate that fasting indices derived from glucose and insulin carry information about future metabolic trajectory, though their accuracy varies by population and cut point 2.
They are not fixed traits, and both can move. The levers a clinician usually reviews first are the unglamorous ones, which are sleep duration and quality, total physical activity including resistance training, overall dietary pattern and alcohol intake, body composition and particularly abdominal fat, and chronic psychological stress.
Why those levers and not others comes back to where insulin acts. Muscle is the largest destination for glucose, the liver is the largest producer of it, and fat tissue is a major influence on how both behave. Research suggests that insulin resistance is associated with excess adiposity and with the metabolic syndrome cluster, which is why body composition features so heavily in any clinical review of these markers 1.
It is also worth setting expectations honestly. Individual baselines differ for reasons outside behaviour, and research suggests that genetic contribution to fasting glucose, fasting insulin and HOMA-IR varies across the distribution of those markers 5. Two people can make identical changes and see different magnitudes of movement, which is an argument for measuring rather than assuming.
Anything beyond lifestyle, including any prescription therapy, is a decision for a licensed provider who has evaluated you, your history and your full results. No article can make that call, and no single lab value should.
Any result outside the reference range on your own report is worth a conversation, and so is a result inside the range that has moved noticeably from your previous draws. Nothing on a lab report should be ignored, and nothing on a lab report is a diagnosis on its own.
Some situations warrant prompt contact rather than a routine appointment. A clearly raised fasting glucose, a raised glucose accompanied by marked thirst, frequent urination, blurred vision or unexplained weight loss, or a pattern of raised glucose with low fasting insulin, are all worth discussing with a clinician promptly. So is any symptom that concerns you, regardless of what the numbers say.
For the common scenario, a normal glucose with a fasting insulin in the upper part of the reference range, the appropriate next step is a review rather than alarm. That means repeating the pair under comparable conditions, adding the companion markers that give context, and discussing the whole picture with a clinician who can see your history.
This page is educational and is not medical advice. Discuss your results, and any treatment, with a clinician or licensed provider who can review your full history.
For related reading, the guide on how to lose weight with insulin resistance covers the practical side of this topic, and is hemoglobin the same as a1c answers a comparable naming question about another commonly confused pair of markers.
No. Fasting glucose measures the sugar circulating in your blood after an overnight fast, while fasting insulin measures the hormone your pancreas is releasing to keep that sugar steady. They are separate tests, reported in different units, against different reference ranges.
Yes, and it is a common pattern. The body defends blood sugar by increasing insulin output, so the glucose reading can stay inside the reference range while the hormone level sits high. That is why the glucose number alone does not tell you how much effort is going into it.
Both are taken from the same blood draw after an 8 to 12 hour fast. Plain water is allowed. Keep the fasting window and the time of day similar each time you test, because insulin responds sharply to recent food and comparability matters more than any single reading.
HOMA-IR is an index that combines your fasting glucose and fasting insulin values into one estimate of insulin resistance. Both values must come from the same fasting sample. It is an estimate rather than a direct measurement, so it is read alongside your other results, not on its own.
That is a decision for your clinician, who will weigh your history, symptoms and other results. Fasting glucose is on most standard panels. Fasting insulin is usually an add on test, and it answers the question glucose cannot, which is how much hormone the result required.
No. HbA1c reflects average glucose exposure over a period of months, which is useful, but it is still a sugar measurement. It does not tell you how much insulin your body is producing to achieve that average, so the two give different information.
Insulin assays are not standardised in the way glucose assays are, so the same sample can produce different figures in different labs. Where possible, repeat testing at the same laboratory under similar conditions so the trend is readable.
Bring it to a clinician rather than acting on it yourself. A wide reference range describes the population tested, not an equally good outcome at every point within it. The usual next step is a repeat test under comparable conditions, plus the companion markers that give context.
A clearly raised fasting glucose, a raised glucose alongside marked thirst, frequent urination, blurred vision or unexplained weight loss, or a raised glucose paired with a low fasting insulin. Any symptom that concerns you is also a reason to make contact, whatever the numbers show.
A licensed provider, after evaluating you and your full set of results. Lab values describe what is happening, they do not determine care on their own, and no article can make that decision for your situation.